 Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Abstract #166620
Audio (mp3) recordingCathy Schoen, MS and Karen Davis, PhD. Senior Vice President, Commonwealth Fund, 1 East 75th Street, New York, NY 10021, 212-606-3824, cs@cmwf.org
To inform national policy development, the Commonwealth Fund's Commission on a High Performance Health System is analyzing federal options for potential short- and long-term savings and opportunities to invest for future gains in value. The five central specifications of the plan are (1) knowledge management and information sharing; (2) promoting health/preventing disease; (3) incentives aligned with health system quality and efficiency; (4) administrative and pricing efficiency; and (5) universal health coverage. Key findings include: it is possible to achieve savings and improve health system performance and Medicare payment changes by themselves can be effective -- but changes involving all payers would be much more effective. The presentation will include new estimates of the likely expenditure effects of each option and estimating the five- and ten-year cumulative impact on total national health spending and the distributional effects across federal and state budgets, employers, and households.
Learning Objectives:
- List and discuss the chief cost drivers in health care and coverage, and their relative importance;
- Identify and discuss critically some proposed strategies for controlling these drivers;
- Discuss the efficacy and limitations of regulatory approaches;
- Discuss the efficacy and limitations of incentives;
- Discuss the efficacy and limitations of system structural reform approaches;
- Discuss the efficacy and limitations of market-focused approaches;
- Discuss the impact of strategies that shift costs to beneficiaries;
- Discuss (a) what opportunities for reform are likely to occur soonest and (b) some of the underlying factors.
Keywords: Cost Issues, Universal Coverage
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA